使用硫酸软骨素和氨基葡萄糖治疗颞下颌关节功能障碍的疗效:系统回顾与荟萃分析。

IF 3.6 2区 地球科学 Q1 GEOSCIENCES, MULTIDISCIPLINARY
Bulletin of Volcanology Pub Date : 2025-01-01 Epub Date: 2022-05-19 DOI:10.1080/08869634.2022.2076796
Víctor Ruiz-Romero, Jorge Toledano-Serrabona, Cosme Gay-Escoda
{"title":"使用硫酸软骨素和氨基葡萄糖治疗颞下颌关节功能障碍的疗效:系统回顾与荟萃分析。","authors":"Víctor Ruiz-Romero, Jorge Toledano-Serrabona, Cosme Gay-Escoda","doi":"10.1080/08869634.2022.2076796","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy of chondroitin sulfate (CS) and glucosamine (GS), the most relevant drugs of \"Symptomatic Slow Acting Drug for Osteoarthritis\" (SYSADOA), in the functional and symptomatic improvement of temporomandibular dysfunction. Although, controversy exists regarding their benefit.</p><p><strong>Methods: </strong>An electronic search was conducted to retrieve randomized controlled clinical trials (RCTs). The risk of bias assessment was evaluated using the Cochrane Collaboration's tool. Data were meta-analyzed with a random effect model whenever possible.</p><p><strong>Results: </strong>Three RCTs were included. Qualitative results showed a decrease in pain, joint noise, and inflammatory biomarkers in synovial fluid and an improvement in maximum mouth opening without significant adverse effects. Meta-analysis showed a significant increase in maximum mouth opening with the use of CS-GS (<i>p</i> = 0.19). No statistically significant differences were found in pain reduction compared to tramadol.</p><p><strong>Conclusion: </strong>CS-GS is effective and safe in the symptomatic and functional improvement of patients with TMD.</p>","PeriodicalId":55297,"journal":{"name":"Bulletin of Volcanology","volume":"79 1","pages":"60-69"},"PeriodicalIF":3.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of the use of chondroitin sulphate and glucosamine for the treatment of temporomandibular joint dysfunction: A systematic review and meta-analysis.\",\"authors\":\"Víctor Ruiz-Romero, Jorge Toledano-Serrabona, Cosme Gay-Escoda\",\"doi\":\"10.1080/08869634.2022.2076796\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To evaluate the efficacy of chondroitin sulfate (CS) and glucosamine (GS), the most relevant drugs of \\\"Symptomatic Slow Acting Drug for Osteoarthritis\\\" (SYSADOA), in the functional and symptomatic improvement of temporomandibular dysfunction. Although, controversy exists regarding their benefit.</p><p><strong>Methods: </strong>An electronic search was conducted to retrieve randomized controlled clinical trials (RCTs). The risk of bias assessment was evaluated using the Cochrane Collaboration's tool. Data were meta-analyzed with a random effect model whenever possible.</p><p><strong>Results: </strong>Three RCTs were included. Qualitative results showed a decrease in pain, joint noise, and inflammatory biomarkers in synovial fluid and an improvement in maximum mouth opening without significant adverse effects. Meta-analysis showed a significant increase in maximum mouth opening with the use of CS-GS (<i>p</i> = 0.19). No statistically significant differences were found in pain reduction compared to tramadol.</p><p><strong>Conclusion: </strong>CS-GS is effective and safe in the symptomatic and functional improvement of patients with TMD.</p>\",\"PeriodicalId\":55297,\"journal\":{\"name\":\"Bulletin of Volcanology\",\"volume\":\"79 1\",\"pages\":\"60-69\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin of Volcanology\",\"FirstCategoryId\":\"89\",\"ListUrlMain\":\"https://doi.org/10.1080/08869634.2022.2076796\",\"RegionNum\":2,\"RegionCategory\":\"地球科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/5/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"GEOSCIENCES, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Volcanology","FirstCategoryId":"89","ListUrlMain":"https://doi.org/10.1080/08869634.2022.2076796","RegionNum":2,"RegionCategory":"地球科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/5/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"GEOSCIENCES, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

目的评估硫酸软骨素(CS)和氨基葡萄糖(GS)这两种 "骨关节炎症状慢作用药物"(SYSADOA)中最重要的药物在改善颞下颌关节功能障碍的功能和症状方面的疗效。尽管如此,关于这些药物的益处仍存在争议:方法:通过电子搜索检索随机对照临床试验(RCT)。使用 Cochrane 协作工具对偏倚风险进行了评估。尽可能使用随机效应模型对数据进行元分析:结果:共纳入了三项临床试验。定性结果显示,疼痛、关节噪音和滑液中的炎症生物标志物均有所减少,最大张口量也有所改善,但无明显不良反应。Meta 分析表明,使用 CS-GS 可显著提高最大张口率(p = 0.19)。与曲马多相比,在减轻疼痛方面没有发现明显的统计学差异:结论:CS-GS 对改善 TMD 患者的症状和功能有效且安全。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Efficacy of the use of chondroitin sulphate and glucosamine for the treatment of temporomandibular joint dysfunction: A systematic review and meta-analysis.

Objective: To evaluate the efficacy of chondroitin sulfate (CS) and glucosamine (GS), the most relevant drugs of "Symptomatic Slow Acting Drug for Osteoarthritis" (SYSADOA), in the functional and symptomatic improvement of temporomandibular dysfunction. Although, controversy exists regarding their benefit.

Methods: An electronic search was conducted to retrieve randomized controlled clinical trials (RCTs). The risk of bias assessment was evaluated using the Cochrane Collaboration's tool. Data were meta-analyzed with a random effect model whenever possible.

Results: Three RCTs were included. Qualitative results showed a decrease in pain, joint noise, and inflammatory biomarkers in synovial fluid and an improvement in maximum mouth opening without significant adverse effects. Meta-analysis showed a significant increase in maximum mouth opening with the use of CS-GS (p = 0.19). No statistically significant differences were found in pain reduction compared to tramadol.

Conclusion: CS-GS is effective and safe in the symptomatic and functional improvement of patients with TMD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Bulletin of Volcanology
Bulletin of Volcanology 地学-地球科学综合
CiteScore
6.40
自引率
20.00%
发文量
89
审稿时长
4-8 weeks
期刊介绍: Bulletin of Volcanology was founded in 1922, as Bulletin Volcanologique, and is the official journal of the International Association of Volcanology and Chemistry of the Earth’s Interior (IAVCEI). The Bulletin of Volcanology publishes papers on volcanoes, their products, their eruptive behavior, and their hazards. Papers aimed at understanding the deeper structure of volcanoes, and the evolution of magmatic systems using geochemical, petrological, and geophysical techniques are also published. Material is published in four sections: Review Articles; Research Articles; Short Scientific Communications; and a Forum that provides for discussion of controversial issues and for comment and reply on previously published Articles and Communications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信